Group 1 (0–4) | Group 2 (5–9) | ||
---|---|---|---|
17 (7.8%) | 5 (2.0%) | ||
Number of events | OR (95% CI) | p Value | |
Model 1 | 1.00 (ref) | 0.24 (0.09 to 0.66) | 0.006 |
Model 2 | 1.00 (ref) | 0.23 (0.08 to 0.63) | 0.004 |
Model 3 | 1.00 (ref) | 0.22 (0.08 to 0.62) | 0.004 |
Model 4 | 1.00 (ref) | 0.24 (0.08 to 0.69) | 0.008 |
Model 5 | 1.00 (ref) | 0.23 (0.08 to 0.63) | 0.004 |
Model 6 | 1.00 (ref) | 0.23 (0.08 to 0.65) | 0.005 |
Model 7 | 1.00 (ref) | 0.18 (0.06 to 0.54) | 0.002 |
Model 8 | 1.00 (ref) | 0.23 (0.08 to 0.63) | 0.004 |
The Mediterranean diet is associated with a lower risk to develop NODAT.
Model 1, crude.
Model 2, adjustment for age and sex.
Model 3, model 2+adjustment for cyclosporine, tacrolimus and prednisolone dose.
Model 4, model 2+adjustment for pre-emptive transplantation and cold ischemia time.
Model 5, model 2+adjustment for total energy intake.
Model 6, model 2+adjustment for smoking and physical activity.
Model 7, model 2+adjustment for triglycerides and HDL-cholesterol concentrations.
Model 8, model 2+adjustment for time between transplantation and baseline.
HDL, high-density lipoprotein; NODAT, new-onset diabetes after transplantation.